InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.00%
)
Bitcoin
66,393.61
(
0.59%
)
Post# of 252189
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: masterlongevity post# 147840

Thursday, 08/30/2012 3:29:45 AM

Thursday, August 30, 2012 3:29:45 AM

Post# of 252189

there were 2000 pts enrolled in the 2 trial. My guess is that at least 60% of them were moderate. That leaves 800 mild patients, 400 active and 400 PBO.

I've read in several reports (for example: http://in.reuters.com/article/2012/08/24/elililly-trial-alzheimer-idINL2E8JO5SY20120824 ), that the majority of patients, roughly two-thirds of them had mild disease. So there were over 1300 mild patients.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up